Institutional investors purchased a net $736.4 thousand shares of CCXI during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 63.15% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 483.7 Thousand shares of ChemoCentryx Inc
BVF PARTNERS LP Bought 415.0 Thousand shares of ChemoCentryx Inc
GRUSS CAPITAL MANAGEMENT LP Bought 413.7 Thousand shares of ChemoCentryx Inc